Shaily Engineering
Stock Snapshot
Price Performance
Vista Outlook
View Technicals Analysis →Basis of our Recommendation
Shaily Engineering is strategically pivoting towards high-margin healthcare manufacturing, particularly in the GLP-1 pen device space, which is expected to drive robust revenue growth and margin expansion. Management's focus on capacity expansion, with significant investments in new facilities, positions the company to meet increasing demand in both healthcare and semiconductor markets. Despite facing headwinds in the consumer segment due to weak demand in Western markets, the company's diversification into high-growth areas is likely to enhance its competitive position. Vista's financial outlook reflects a projected revenue growth of 29.3% CAGR, with margins expected to expand significantly, supported by long-term contracts and a unique market position in GLP-1 devices. The overall macro environment in India remains constructive, bolstered by government spending and improving manufacturing conditions, although inflationary pressures could pose challenges. Over the next 12-24 months, key opportunities include the successful execution of large pen injector orders and the ramp-up of semiconductor tray supplies, while watchpoints include the ongoing weakness in the consumer business and geopolitical risks affecting input costs
Why We Like This Stock
- Strong growth potential in the healthcare segment, particularly with GLP-1 pen injectors, projected at 29.3% CAGR
- Significant capacity expansion plans, including new facilities in South India and Abu Dhabi, to support long-term demand
- Diversification into high-growth semiconductor markets enhances competitive positioning and revenue streams
Things To Watch Out For
- Weak demand in the consumer segment, particularly in Western markets, poses risks to overall revenue growth
- Operational challenges in achieving efficiency on new pen injector lines may impact margin expansion
- Geopolitical uncertainties could affect input costs and logistics, potentially impacting profitability
Key Parameters
Financial Snapshot
| Actuals | Forecast | ||||
|---|---|---|---|---|---|
| FY24 | FY25 | FY26 | FY27 | FY28 | |
| Revenue (Cr.) | 644 | 787 | 991 | 1,024 | 1,207 |
| Profit Before Tax (Cr.) | 70 | 119 | 223 | 263 | 302 |
| PBT Margin | 10.9% | 15.1% | 2250.3% | 25.7% | 25.1% |
| Net Profit (Cr.) | 61 | 96 | 179 | 211 | 242 |
| Earnings Per Share | 13.3 | 21.0 | 38.9 | 45.8 | 52.6 |
Analyst Recommendations
| Broker | Recommendation | Target Price | Date |
|---|---|---|---|
| Moneycontrol | ► Equalweight | nan | 25-Jun-2026 |
| Motilal Oswal | ▲ Buy | 4,074 | 10-Aug-2026 |
| UBS | ▲ Buy | 4,000 | 04-Jun-2026 |
| Ventura | ▲ Buy | 3,124 | 06-May-2026 |
Company Overview
Show Company Profile
Shaily Engineering Plastics Limited engages in the manufacture and sale of precision injection moulded plastic components/products in India. The company offers specialty devices, platform devices, inhalers, sprays and pumps, intricate insulin injector pens, auto-injectors, and specialty packaging and containers for solid and liquid formulations, as well as providing contract development and manufacturing services for the pharmaceutical industry. It also offers kitchen and cooking devices, and storage and cleaning products; and sheet steel furniture products, including cabinets, drawer units, tables, and storage units. In addition, the company provides plastic components for lighting, appliances, and automotive applications; and razors, pumps, sprays and packaging for the personal care market. It also exports its products to approximately 40 countries. Shaily Engineering Plastics Limited was incorporated in 1980 and is based in Vadodara, India.